Your browser doesn't support javascript.
loading
HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase.
Ginzel, Joshua D; Acharya, Chaitanya R; Lubkov, Veronica; Mori, Hidetoshi; Boone, Peter G; Rochelle, Lauren K; Roberts, Wendy L; Everitt, Jeffrey I; Hartman, Zachary C; Crosby, Erika J; Barak, Lawrence S; Caron, Marc G; Chen, Jane Q; Hubbard, Neil E; Cardiff, Robert D; Borowsky, Alexander D; Lyerly, H Kim; Snyder, Joshua C.
Afiliação
  • Ginzel JD; Department of Cell Biology, Duke University Medical Center, Durham, North Carolina.
  • Acharya CR; Department of Surgery, Division of Surgical Sciences, Duke University Medical Center, Durham, North Carolina.
  • Lubkov V; Department of Cell Biology, Duke University Medical Center, Durham, North Carolina.
  • Mori H; Department of Surgery, Division of Surgical Sciences, Duke University Medical Center, Durham, North Carolina.
  • Boone PG; Department of Pathology and Laboratory Medicine and The Center for Immunology and Infectious Disease, University of California-Davis, Davis, California.
  • Rochelle LK; Department of Cell Biology, Duke University Medical Center, Durham, North Carolina.
  • Roberts WL; Department of Surgery, Division of Surgical Sciences, Duke University Medical Center, Durham, North Carolina.
  • Everitt JI; Department of Cell Biology, Duke University Medical Center, Durham, North Carolina.
  • Hartman ZC; Department of Cell Biology, Duke University Medical Center, Durham, North Carolina.
  • Crosby EJ; Department of Pathology, Duke University Medical School, Durham, North Carolina.
  • Barak LS; Department of Surgery, Division of Surgical Sciences, Duke University Medical Center, Durham, North Carolina.
  • Caron MG; Department of Pathology, Duke University Medical School, Durham, North Carolina.
  • Chen JQ; Department of Surgery, Division of Surgical Sciences, Duke University Medical Center, Durham, North Carolina.
  • Hubbard NE; Department of Cell Biology, Duke University Medical Center, Durham, North Carolina.
  • Cardiff RD; Department of Cell Biology, Duke University Medical Center, Durham, North Carolina.
  • Borowsky AD; Department of Pathology and Laboratory Medicine and The Center for Immunology and Infectious Disease, University of California-Davis, Davis, California.
  • Lyerly HK; Department of Pathology and Laboratory Medicine and The Center for Immunology and Infectious Disease, University of California-Davis, Davis, California.
  • Snyder JC; Department of Pathology and Laboratory Medicine and The Center for Immunology and Infectious Disease, University of California-Davis, Davis, California.
Mol Cancer Res ; 19(10): 1699-1711, 2021 10.
Article em En | MEDLINE | ID: mdl-34131071
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Isoformas de Proteínas / Carcinogênese Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Isoformas de Proteínas / Carcinogênese Idioma: En Ano de publicação: 2021 Tipo de documento: Article